Original Research

Afatinib reverses ceritinib resistance (CR) in ALK/ROS1-positive non-small-cell lung cancer cell (NSCLC) via suppression of NRG1 pathway

Chen H, Zhang Q, Zhang Y, Jia B, Zhang B, Wang C

OncoTargets and Therapy 2018, 11:8201-8209

Published Date: 26 November 2018